Drug "quantity procurement" means centralized drug procurement. Generally speaking, it is the most popular "group buying" at the national level. "Procurement with quantity" is the centralized procurement of drugs with "country" as the unit. By negotiating with upstream suppliers (pharmaceutical companies or distributors), centralized large-scale procurement can obtain lower purchase prices and help downstream (medical institutions, etc.). ) save costs, improve procurement efficiency, and achieve the effect of controlling costs. This method adheres to the direction of "purchasing by quantity, linking quantity with price, and integrating recruitment with procurement" to promote the return of drug prices to a reasonable level, with the aim of realizing the goal of "exchanging quantity for price" for the benefit of the people.

People's Republic of China (PRC) Drug Administration Law

Article 84

The state has improved the drug procurement management system, monitored drug prices, conducted cost price surveys, strengthened drug price supervision and inspection, investigated and dealt with illegal drug price behaviors such as price monopoly and price gouging according to law, and maintained drug price order. Article 85

For drugs that are subject to market-regulated prices according to law, drug marketing license holders, drug production enterprises, drug trading enterprises and medical institutions shall set prices in accordance with the principles of fairness, reasonableness, honesty and credibility, and consistency between quality and price, so as to provide users with drugs with reasonable prices;

Drug marketing license holders, pharmaceutical production enterprises, pharmaceutical trading enterprises and medical institutions shall abide by the provisions of the competent department of drug prices in the State Council on drug price management, set and indicate the retail price of drugs, and prohibit profiteering, price monopoly and price fraud. Article 86

Holders of drug marketing licenses, pharmaceutical production enterprises, pharmaceutical trading enterprises and medical institutions shall provide information such as the actual purchase and sale price and quantity of their drugs to the competent department of drug prices according to law.